Application of drug–metal ion interaction principle in conductometric determination of imatinib, sorafenib, gefitinib and bosutinib
An analytical method for the quantification of anticancer agents such as imatinib, sorafenib, gefitinib and bosutinib using conductometry was developed. Each drug solution was mixed with measured concentration of metal ion (Cu2+) solution resulting in drug–metal ion complexation in the titration cel...
Main Authors: | Alhazmi Hassan A., Ali Bokar Nasib AbdulRhman, Musleh Yasser Ali, Hijri Khaled Qassim, Rehman Zia ur, Khuwaja Gulrana, Al-Bratty Mohammed, Javed Sadique A., Arbab Ismail A. |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2020-07-01
|
Series: | Open Chemistry |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/chem.2020.18.issue-1/chem-2020-0123/chem-2020-0123.xml?format=INT |
Similar Items
-
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
by: Anna Kreutzman, et al.
Published: (2019-09-01) -
Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
by: Qiuying (Selina) Liu, et al.
Published: (2021-05-01) -
Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia
by: Akiko Mita, et al.
Published: (2018-04-01) -
Synthesis of Bosutinib from 3-Methoxy-4-hydroxybenzoic Acid
by: Xiao Jia Yin, et al.
Published: (2010-06-01) -
A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors
by: Nagla Abdel Karim, et al.
Published: (2022-12-01)